Adenine

DB00173ApprovedInvestigationalNutraceuticalSmall molecule

Adenine is a purine base which forms a component of DNA among other functions and is present in many multivitamins. A nutrient that is included in many multivitamins.

Mechanism: Adenine forms adenosine, a nucleoside, when attached to ribose, and deoxyadenosine when attached to deoxyribose, and it forms adenosine triphosphate (ATP), which drives many cellular metabolic processes by transferring chemical energy between reactions.
Curator reviewed
Primary indication: For nutritional supplementation, also for treating dietary shortage or imbalanceCurator reviewed
Formula / weight: C₅H₅N₅ · 135.1267 g/mol (avg)
First approval: Canada, 2012 · United States, 1980
Also known as: 6-Aminopurine · Adenin · Vitamin B4
Brand names: As 3
Cpda-1 Blood Collection System
Leukotrap
Rejuvesol

Resolves to

Compound

UNIIJAC85A2161CAS73-24-5ChEMBLCHEMBL226345ChEBI16708PubChem190KEGGD00034

Clinical / RWD

RxNorm290PharmGKBPA448048

Structure

InChIKeyGFFGJBXGBJISGV-UHFFFAOYSA-NSMILESNC1=C2NC=NC2=NC=N1

Targets

P07741APRTQ13126MTAPQ05603cobTO00763ACACBP24666ACP1P0AF12mtnNQ9BY49PECRP17802mutY+3 more

What you can answer from here — as of September 23, 2026

12Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

87Drug interactionsStructured to mechanism, not free text

9Clinical trialsPhase, status and sponsor resolved per trial

129Marketed productsAcross 3 countries and 15 labellers

28+ReferencesStructured and connected to the statements they support

Which drugs share a target with Adenine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Log In Paid Account Log In